Lanean...

Alloantibodies in von Willebrand disease

The development of alloantibodies against von Willebrand factor (VWF) represents a rare but serious complication of treatment of von Willebrand disease (VWD), occurring in ∼5% to 10% of type 3 VWD patients. Affected patients can present with a range of symptoms, including lack or loss of hemostatic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: James, Paula D., Lillicrap, David, Mannucci, Pier M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731926/
https://ncbi.nlm.nih.gov/pubmed/23297130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-462085
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!